SCHEMBL21591534

SCHEMBL21591534

O=C1CCCN1CCCN(Cc1ccncc1)Cc1coc2ccccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 4/20 0.49
▸ CYP11B2 P19099 4/20 0.49
▸ CYP17A1 P05093 2/20 0.49
▸ CYP19A1 P11511 2/20 0.49
▸ SIGMAR1 Q99720 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ APOBEC3A P31941 1/20 0.35
▸ APOBEC3G Q9HC16 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TNFSF11 O14788 1/20 0.35
▸ ADRA1B P35368 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21591521 0.84 CYP11B1 (0.56) CYP11B1CYP11B2CYP17A1CYP19A1SIGMAR1
SCHEMBL21591440 0.81 CYP11B1 (0.60) CYP11B1CYP11B2CYP17A1CYP19A1SIGMAR1
SCHEMBL21591524 0.81 CYP11B1 (0.53) CYP11B1CYP11B2CYP17A1CYP19A1SIGMAR1
SCHEMBL21591502 0.80 CYP11B1 (0.59) CYP11B1CYP11B2CYP17A1CYP19A1KMT2A
SCHEMBL21591499 0.80 CYP11B1 (0.51) CYP11B1CYP11B2CYP17A1CYP19A1SIGMAR1
SCHEMBL21591454 0.78 CYP11B1 (0.58) CYP11B1CYP11B2CYP17A1CYP19A1KMT2A
SCHEMBL21591431 0.78 CYP11B1 (0.48) CYP11B1CYP11B2CYP17A1CYP19A1SIGMAR1
SCHEMBL21591463 0.76 CYP11B1 (0.54) CYP11B1CYP11B2CYP17A1CYP19A1SIGMAR1
SCHEMBL21591457 0.76 CYP11B1 (0.54) CYP11B1CYP11B2CYP17A1CYP19A1SIGMAR1
SCHEMBL21591494 0.70 CYP11B1 (0.52) CYP11B1CYP11B2CYP17A1CYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12162863-B2 Modulators of stimulator of interferon genes (STING) Ryvu Therapeutics S.A. (PL) 2024-12-10 — — US disclosed
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-12-22 — — US disclosed
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-12-22 — — US disclosed
EP-3807264-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2021-04-21 — — EP disclosed
WO-2019238786-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2019-12-19 — — WO disclosed
WO-2019238786-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2019-12-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12162863-B2 Modulators of stimulator of interferon genes (STING) STING1, IRF3, CGAS CYP11B1 43/4885CYP11B2 50/4885CYP17A1 914/4885
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) STING1, IRF3, CGAS CYP11B1 43/4885CYP11B2 50/4885CYP17A1 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback